The Galien Foundation
medal
Join us

    The Galien Foundation
      Prix Galien Medal
      Join us
      Prix Galien Coin
      Join us

      2025 Prix Galien USA Laureates

      dropdown-iconBest Pharmaceutical Product

      Yeztugo® - Gilead Sciences

      dropdown-iconBest Biotechnology Product

      Dupixent® - Regeneron and Sanofi

      dropdown-iconBest Product for Rare/Orphan Diseases

      VORANIGO® - Servier Pharmaceuticals

      dropdown-iconBest Medical Technology

      Edwards EVOQUE Transcatheter Tricuspid Valve Replacement System - Edwards Lifesciences

      dropdown-iconBest Digital Health Solution

      Oura Ring 4 - ŌURA

      dropdown-iconBest Incubator / Accelerator / Equity

      Endless Frontier Labs - New York University Stern School of Business - Endless Frontier Labs

      dropdown-iconBest Startup

      Biotechnology category: Dren Bio

      Medical Technology / Digital Health: Resuscitec GmbH

      PGU 2025 winners

      Prix Galien USA 2025 Laureates

      Best Pharma winners 2025

      Best Pharmaceutical Product

      Best Biotech winners 2025

      Best Biotechnology Product

      Best Rare-Orphan winners 2025

      Best Product for Rare/Orphan Diseases

      Best Medtech winners 2025 webp

      Best Medical Technology

      Best DH winners 2025

      Best Digital Health Solution

      Best IAE winners 2025

      Best Incubator/Accelerator/Equity

      Best Startup 1 winners 2025

      Best Startup (Medtech/Digital Health)

      Best Startup 2 winners 2025

      Best Startup (Biotech) 

      An exciting roster of innovations was vying for the gold in the seven categories in competition presented during the Galien Week of Innovation.

      Categories: Best Medical Technology, Best Digital Health Solution, Best Incubator/Accelerator/Equity, Best Startup

      MED1
      MED2
      MED3
      MED4
      DH1
      DH2
      DH3
      DH4
      IAE1
      IAE2
      IAE3
      Startup1
      Startup2
      Startup2-1
      Startup3-1
      Startup4-1
      Startup5
      Startup6

      Categories: Best Pharmaceutical Product, Best Biotechnology Product, Best Product for Rare/Orphan Diseases

      PHARMA1
      PHARMA2
      PHARMA3
      BIO1
      BIO2
      BIO3
      RARE1
      RARE2
      RARE3

      Submission Process

      Submission is a simple, easy process. Watch our short 3-minute video for a complete explanation of your submission from login to submission, dashboard and upload of all required company assets.

      The Prix Galien USA Awards Ceremony launched in 2007, first honoring unique medical products, later devices, and finally, individuals who have impacted patient care through innovation. The Awards Ceremony and Dinner is held annually at the New York City Museum of Natural History following the Galien Forum, which launched in New York City in 2010 and has since been held every autumn the Alexandria Center for Life Science – New York City. We award prizes for Best Pharmaceutical Product, Best Biotechnology Product, and Best Medical Technology approved by the FDA in the past five years as well as Best Digital Health Solution, Best Incubator/Accelerator/Equity and best Startup. Up to three prizes may be awarded annually in each of these categories. The prizes are awarded by a prestigious committees including Nobel laureates, industry leaders and other highly distinguished individuals in the health sector. Learn about our charter and selection criteria.

      Any team member having worked on a Prix Galien Winning or Prix Galien nominated product or device is considered an alumnus by the Galien Foundation. We encourage our alumni to take an active part in our growing community by telling their stories from challenge to change for the benefit of human health worldwide.


      The Prize boasts an illustrious list of winners who have entered the Galien Foundation Hall of Fame. The winners archive traces the history of innovations benefitting human health since the prize’s inception in France in 1970. It is with pride that the Galien Foundation chronicles and honors the winning teams and encourages individuals having working on breakthrough products, devices and solution to become Foundation members and thus perpetuate the importance of their innovation to the advancement of human health.

      The Prize is awarded in 15 countries worldwide. Winners are candidates for the bi-yearly International prize contending with all prize-winning innovations worldwide.

      Prix Galien USA Awards Committee

      The Prix Galien USA Awards committees include up to 13 esteemed leaders in the life sciences from the United States with one international member and one honorary member. Two committees judge three categories each.

      JUDGES IN THE CATEGORIES:

      Best Pharmaceutical Product, Best Biotechnology Product, and Best Product for Rare/Orphan Diseases:

      JUDGES IN THE CATEGORIES:

      Best Medical Technology, Best Digital Health Solution, Best Incubator / Accelerator / Equity, and Best Startup:

      IN MEMORIAM - BERNARD POUSSOT, COMMITTEE CHAIR (2014-2024)

      MEDICAL TECHNOLOGY SUB-COMMITTEE:

      This sub-committee pre-screens all applications in the Medical Technology category before submission of the short list

      Robert S. LANGER
      Robert S. LANGER
      David H. Koch Institute Professor, Massachusetts Institute of Technology
      Cato_Laurencin
      Sir Cato T. LAURENCIN, MD, PhD, KCSL
      Chief Executive Officer, The Cato T. Laurencin Institute at UConn; The University Professor and Van Dusen Distinguished Endowed Professor, University of Connecticut
      STEVEN LESTER
      Steven J. LESTER, MD
      Medical Director, Discovery Oasis; Founder and Chief Medical Officer, Mayo Clinic and ASU Alliance for Health Care Accelerator

      INCUBATOR, ACCELERATOR, EQUITY, SUB-COMMITTEE:

      This sub-committee pre-screens all applications in the IAE category before submission of the short list

      Gil BASHE (Sub-Committee Jury Chair)
      Gil BASHE
      Managing Partner, Chair Global Health and Purpose, FINN Partners
      Ron COHEN, MD
      Ron COHEN, MD
      Founder, President & CEO, Acorda Therapeutics
      Jamey EDWARDS
      Jamey EDWARDS
      Former CEO, Emergent Medical Associates
      Amir KALALI, MD
      Amir KALALI, MD
      Chairman & Chief Curator, CNS Summit/Co-Chair, Decentralized Trial Research Alliance
      Michelle LONGMIRE, MD
      Michelle LONGMIRE, MD
      Co-Founder & CEO, Medable
      James PRUTOW, JD, MBA
      James PRUTOW, JD, MBA
      Advisory Partner – Life Sciences, Molecular Diagnostics, Global Healthcare, PwC Consulting
      Julien de SALABERRY
      Julien de SALABERRY
      CEO & Founder, Galen Growth

      DIGITAL HEALTH ADVISORY BOARD:

      The Digital Health advisory board pre-screens all applications in the Digital Health category before submission of the short list

      Junaid BAJWA
      Junaid BAJWA
      Senior Partner & Head of UK, Flagship Pioneering
      Maggie Hott
      Maggie HOTT
      Global GTM Lead, Healthcare & Life Science, OpenAI
      Group 916
      Rodolphe KATRA
      VP & Global Chief AI Officer, Medtronic
      Sachin NANAVATI
      Sachin NANAVATI
      General Manager, OpenEvidence
      MaryAnn_Rizk
      MaryAnne RIZK
      Managing Director, Global Head of Life Sciences Clinical Strategy, Amazon Web Services
      Sally Ann Frank
      Sally Ann FRANK
      Worldwide Lead, Health & Life Sciences, Microsoft for Startups

      STARTUP ADVISORY BOARD:

      The Start-up advisory board pre-screens all applications in the StartUp category before submission of the short list

      Elaine BRENNAN
      Elaine BRENNAN
      Executive Director, Global Strategic Partnership, Northwell Health
      Charles André-1
      Charles-André BROUWERS
      Founder & Managing Partner, Galileo Life Sciences
      Anuj Desai-1
      Anuj DESAI
      Senior Director, Channel Alliances, Pfizer
      Steve Eror-1
      Steven EROR
      Chairman & CEO, Solo-Dex; Private Investor, Hilltop Group
      Michael LANGER
      Michael LANGER
      Founder & Managing Partner, T.Rx Capital
      Claire Leurent-1
      Claire LEURENT
      Managing Director, AbbVie Ventures
      Detlev MENNERICH
      Detlev MENNERICH
      Global Head, Boehringer Ingelheim Venture Fund
      Leighanne Oh
      Leighanne OH
      Vice President, Ascenta Capital
      Uwe-1
      Uwe SCHOENBECK
      Venture Partner, Canaan Ventures